Asahi Songwon Colors’ 3 Growth Drivers: Pigments, AZO and APIs Power Specialty Chemicals Shift

Asahi Songwon Colors is transforming from a traditional pigment manufacturer into a diversified specialty chemicals company, expanding its presence across pigments, APIs and intermediates. The company is focusing on higher capacity utilisation, product diversification, operational efficiency and export-led growth to build a broader business platform.

The company operates four manufacturing facilities in Padra, Odhav, Dahej and Chhatral and supplies customers across 19 countries. Exports accounted for around 69 per cent of FY26 revenue, underlining its strong international presence. Around 80 per cent of its business comes from repeat customers, providing a stable base of long-term customer relationships.

Asahi Songwon reported a strong improvement in its financial performance during Q1FY27. Revenue from operations increased 26 per cent year on year to Rs 188.9 crore from Rs 149.87 crore in Q1FY26. EBITDA surged 171 per cent year on year to Rs 32.59 crore, with the EBITDA margin expanding to 17.3 per cent from 8 per cent. Profit after Tax jumped 634 per cent year on year to Rs 19.02 crore, exceeding the Rs 18 crore PAT recorded for the entire FY26.

The improvement was driven by stronger performance in the core pigment business, better operating leverage and tighter cost management. The company is also working towards deleveraging and improving its balance sheet.

Blue pigments continue to form the company’s key business, supported by backward integration, established customer relationships and high switching barriers. Capacity utilisation in the segment is around 80-85 per cent. Instead of pursuing significant capacity expansion, the company plans to drive growth through debottlenecking, efficiency improvements and the development of higher-value products.

Asahi Songwon has also expanded into AZO pigments through its association with Tennants Textiles Colours. The business is positioned to benefit from the China plus one strategy, as global customers look to diversify sourcing and establish alternative manufacturing bases. AZO pigments generated around Rs 78 crore in revenue during FY26 and reached EBITDA profitability and cash break-even. The company expects the segment’s performance to improve further as capacity utilisation increases.

Through Atlas Life Sciences, the company has entered the API market, manufacturing products across therapeutic categories including anti-convulsant, anti-psychotic and anti-diabetic APIs. The API business has faced pricing pressure, particularly in Pregabalin. However, prices have started recovering from their lows. Higher utilisation and regulatory approvals remain important factors for improving the segment’s contribution.

Asahi Songwon’s growth strategy is centred on improving utilisation, developing new products and expanding exports. Its three key growth engines — blue pigments, AZO pigments and APIs — provide increasing diversification beyond its traditional pigment business. With strong export exposure, established customer relationships and improving profitability, the company is positioning itself as a broader specialty chemicals platform. Key factors to monitor include capacity utilisation, API pricing, regulatory approvals, AZO ramp-up and sustained margin improvement.

Disclaimer: The article is for informational purposes only and not investment advice.